Fitch Affirms Ratings on Goldman Sachs (GS); Outlook Raised to Stable
Tweet
Share
E-mail
Up)
Fitch affirmed Goldman Sachs' (NYSE: GS) A+ long-term Issuer Default Rating and also revised the outlook from Negative to Stable.
The ratings agency attributed the affirmation to "resilience throughout the crisis and the firm's de-levered balance sheet, strong liquidity profile, proven earnings power and strong franchise despite some of the ongoing regulatory uncertainties and somewhat difficult operating environment. In response to regulatory changes and to reduce risk, the firm has scaled back or eliminated certain proprietary trading activities. Goldman has maintained its extensive sales and trading platform, and leading advisory and underwriting positions in the global markets, while positioning itself well for potential future stresses."
As for the more optimistic outlook, Fitch said a Stable outlook "incorporates the resolution of some of the legal and regulatory matters that precipitated the Negative Outlook on May 2, 2010. The most significant resolution since May 2010 was the $550 million settlement with the SEC regarding the ABACUS transaction in which Goldman acted as the underwriter."
The ratings agency attributed the affirmation to "resilience throughout the crisis and the firm's de-levered balance sheet, strong liquidity profile, proven earnings power and strong franchise despite some of the ongoing regulatory uncertainties and somewhat difficult operating environment. In response to regulatory changes and to reduce risk, the firm has scaled back or eliminated certain proprietary trading activities. Goldman has maintained its extensive sales and trading platform, and leading advisory and underwriting positions in the global markets, while positioning itself well for potential future stresses."
As for the more optimistic outlook, Fitch said a Stable outlook "incorporates the resolution of some of the legal and regulatory matters that precipitated the Negative Outlook on May 2, 2010. The most significant resolution since May 2010 was the $550 million settlement with the SEC regarding the ABACUS transaction in which Goldman acted as the underwriter."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BayCom Corp (BCML) Misses Q1 EPS by 4c
- NRx Pharmaceuticals (NRXP) Prices $2M Share Offering at $3.30/sh
- Zura Bio (ZURA) Enters $112.5M Private Placement
Create E-mail Alert Related Categories
Credit RatingsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
